Your AI-Trained Oncology Knowledge Connection!
Opinion
Video
Key Takeaways and Future Perspectives for In-House Biomarker Testing
Author(s):
Panelists discuss how in this discussion the top 3 key points were patient-centric care, enhanced multidisciplinary coordination, and increased access and equity. In the next 3 to 5 years there will be more decentralized testing, potentially more practices participating in genomic profiling, the cost of testing will go down and the turnaround time will be shorter.
Video series above is prompted by the following:
- What are some key takeaways from today’s program?
- How do you see the role of in-house testing evolving over the next 3 to 5 years?
Related Videos
Related Content
%20(1).jpg?fit=crop&auto=format)
